These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25057891)

  • 1. Comparison of second-echelon treatments for Ménière's disease.
    Basura GJ; Lin GC; Telian SA
    JAMA Otolaryngol Head Neck Surg; 2014 Aug; 140(8):754-61. PubMed ID: 25057891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of endolymphatic sac shunting with local steroids for Meniere's disease.
    Wick CC; Manzoor NF; McKenna C; Semaan MT; Megerian CA
    Am J Otolaryngol; 2017; 38(3):285-290. PubMed ID: 28214024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endolymphatic sac decompression as a treatment for Meniere's disease.
    Durland WF; Pyle GM; Connor NP
    Laryngoscope; 2005 Aug; 115(8):1454-7. PubMed ID: 16094123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endolymphatic mastoid shunt versus endolymphatic sac decompression for Ménière's disease.
    Brinson GM; Chen DA; Arriaga MA
    Otolaryngol Head Neck Surg; 2007 Mar; 136(3):415-21. PubMed ID: 17321870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Middle ear exploration in patients with Ménière's disease who have failed outpatient intratympanic gentamicin therapy.
    Crane BT; Minor LB; Della Santina CC; Carey JP
    Otol Neurotol; 2009 Aug; 30(5):619-24. PubMed ID: 19503016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic gentamicin treatment after endolymphatic sac surgery.
    Gouveris H; Lange G; Mann WJ
    Acta Otolaryngol; 2005 Nov; 125(11):1180-3. PubMed ID: 16353396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
    Rajan GP; Din S; Atlas MD
    J Laryngol Otol; 2005 May; 119(5):391-5. PubMed ID: 15949105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratympanic dexamethasone, intratympanic gentamicin, and endolymphatic sac surgery for intractable vertigo in Meniere's disease.
    Sennaroglu L; Sennaroglu G; Gursel B; Dini FM
    Otolaryngol Head Neck Surg; 2001 Nov; 125(5):537-43. PubMed ID: 11700457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summating potential and action potential ratio in Meniere's disease before and after treatment.
    Orchik DJ; Shea JJ; Ge NN
    Am J Otol; 1998 Jul; 19(4):478-82; discussion 483. PubMed ID: 9661758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Individual management of Meniere's disease and evaluation of functional outcome].
    Chen Y; Yang J; Wu H; Huang Q; Wang Z; Zhang Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Aug; 25(16):721-5. PubMed ID: 22070076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratympanic gentamicin for Ménière's disease: effect on quality of life as assessed by Glasgow benefit inventory.
    Banerjee AS; Johnson IJ
    J Laryngol Otol; 2006 Oct; 120(10):827-31. PubMed ID: 16707038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V; Carner M; Colletti L
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endolymphatic sac surgery versus intratympanic gentamicin for the treatment of intractable Ménière's disease: a retrospective review with survey.
    Paradis J; Hu A; Parnes LS
    Otol Neurotol; 2013 Oct; 34(8):1434-7. PubMed ID: 23846192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of intractable Ménière's disease after intratympanic injection of gentamicin.
    Rah YC; Han JJ; Park J; Choi BY; Koo JW
    Laryngoscope; 2015 Apr; 125(4):972-8. PubMed ID: 25363447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA; Chen DA; Arriaga MA
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.